The Global Vyndaqel HCP Lead owns the global healthcare professional (HCP) strategy and the tactics that put it into action for Vyndaqel (Vyndamax in the US), a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM). The role shapes the brand’s long-term narrative and competitive differentiation as the scientific and market landscape evolves, while continuing to support disease awareness and diagnosis. It reports to the Global Vyndaqel Lead and works closely with the global ATTR-CM cross-functional team, including ICO, Medical, the US organization, and other functions. The position leads global brand planning, HCP promotional resource development, and strategic integration across congress and medical education activity. It also drives cross-functional strategic alignment, leads the Brand Strategy Refresh process, and owns global business performance commentary. The role is a 12-month secondment, with potential to become a full-time position. It is considered flexible, with colleagues expected to meet Log In For Your Day requirements at their site (approximately 2.5 days per week in office). Global travel is required approximately once per quarter. The role is posted at multiple Pfizer locations, and the employee’s current work location will not change.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Senior